BioGeneration Ventures Founded 2006
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$13M
Portfolio companies 14
Rounds per year 0.93
Lead investments 9
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.36
Exits -
Key employees -
Stages of investment
Early Stage Venture
Areas of investment
Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Therapeutics
Summary

In 2006 was created BioGeneration Ventures, which is appeared as VC. The main office of represented VC is situated in the Naarden. The company was established in Europe in The Netherlands.

The top amount of exits for fund were in 2015. Deals in the range of 10 - 50 millions dollars are the general things for fund. Comparing to the other companies, this BioGeneration Ventures performs on 10 percentage points less the average number of lead investments. Considering the real fund results, this VC is 23 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is generally included in less than 2 deals every year.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the BioGeneration Ventures, startups are often financed by Thuja Capital, NV NOM, MedSciences Capital. The meaningful sponsors for the fund in investment in the same round are Forbion Capital Partners, New Science Ventures, BOM Capital. In the next rounds fund is usually obtained by Omnes Capital, Forbion Capital Partners, Erasmus MC Biomedical Fund.

Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight AcertaPharma, Mellon Medical, Scenic Biotech. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Therapeutics, Health Care. For fund there is a match between the location of its establishment and the land of its numerous investments - The Netherlands.

Besides them, we counted 5 critical employees of this fund in our database.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
arGEN-X
Biotechnology
Clinical Trials
Therapeutics
Series A
4M11 Feb 2010 Netherlands, Rotterdam
NorthSea Therapeutics
Biotechnology
Health Care
Therapeutics
Series B
36M08 Jan 2020 Netherlands, Naarden
VarmX
Manufacturing
Pharmaceutical
Therapeutics
Series B
37M08 Jul 2020 Netherlands, Leiden
Lanthio Pharma
Biotechnology
Pharmaceutical
Therapeutics
Series A
5M28 Nov 2012 Netherlands, Groningen
Scenic Biotech
Biometrics
Biotechnology
Collaborative Consumption
Life Science
Series A
7M05 Jun 2017 Netherlands, Amsterdam
Synaffix BV
Biotechnology
Therapeutics
Series A
18 Feb 2014 Netherlands, Oss
Mellon Medical
Manufacturing
Medical
Medical Device
Series B
7M30 Aug 2017 Netherlands, Nijmegen
Cristal Therapeutics
Biotechnology
Medical
Pharmaceutical
Therapeutics
Venture - Series Unknown
7M15 Dec 2014 Netherlands, Maastricht
Cristal Therapeutics
Biotechnology
Medical
Pharmaceutical
Therapeutics
Venture - Series Unknown
15M19 Jan 2017 Netherlands, Maastricht
Citryll
Biopharma
Biotechnology
Medical
Medical Device
Neuroscience
Series B
21M02 Jul 2020 Netherlands, Oss
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioGeneration Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: